The New England Journal of Medicine
-
KJ’s ‘Thriving’ a Year After Gene Editing Therapy Treats Rare Disease
It’s been a year since KJ, a Clifton Heights infant, received the world’s first personalized gene editing therapy to treat his rare disease. KJ Muldoon…
Founding Partners
Advertisement
Affiliate Partners
Chamber Partners
